Baiju Kalesh

KKR & Co. is exploring options including selling its controlling stake in India’s JB Chemicals & Pharmaceuticals Ltd. amid interest from potential buyers, according to people familiar with the matter.

Tata Group is considering buying Walt Disney Co.’s stake in Tata Play Ltd. to give it full control of the subscription television broadcaster, people familiar with the matter said, continuing a shakeup in India’s media industry.

Blackstone Inc. aims to add an additional $25 billion of Indian private equity assets over the next five years, reflecting the South Asian country’s increasing allure to global investors.

Blackstone Inc. aims to add an additional $25 billion of Indian private equity assets over the next five years, reflecting the South Asian country’s increasing allure to global investors.The New York-based firm also intends to bring on 20 more investment professionals to its asset management business in India and double its office space in Nariman Point in downtown Mumbai, according to its head of private equity in Asia, Amit Dixit.“India’s predictable regulatory and policy environment, steady e…

(Bloomberg) -- KKR & Co. is considering an acquisition of Indian medical-device maker Healthium Medtech Ltd., according to people familiar with the...

(Bloomberg) -- KKR & Co. is acquiring Bengaluru-based medical device maker Healthium Medtech Ltd. from private equity firm Apax Partners, in another example ...

Brookfield Asset Management Ltd. is planning to invest about $500 million for a majority stake in Indian renewable power firm Leap Green Energy Ltd., according to people familiar with the matter.

(Bloomberg) -- Walt Disney Co. has struck a deal to sell its minority stake in a subscription television broadcaster to Tata Group, people familiar with the ...

Hyundai Motor Co. has brought in Kotak Mahindra Bank Ltd. and Morgan Stanley as advisers on a potential initial public offering of its India unit, according to people familiar with the matter, as the automaker considers what might be one of the biggest-ever listings in the South Asian country.

Mankind Pharma Ltd. is emerging as the frontrunner to acquire Bharat Serums & Vaccines Ltd. in a deal that could value the target company at around $1.5 billion, according to people with knowledge of the matter.